Trial intelligence / Profile preview

Hypertonic saline and blood electrolytes, acid-base balance and blood pressure hormones

2013-004466-34Phase 4Terminated

Sponsor
HUS Eye Hospital
Start
Dec 2013
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sodium chloride in ocular hypertension, sponsored by HUS Eye Hospital. Primary endpoint: Blood samples after hypertonic saline. Started Dec 2013; status: terminated.

02

Drugs

sodium chloride
03

Conditions

ocular hypertension

Beyond the preview

Go deeper on 2013-004466-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004466-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call